Insulin Aspart

CAS 116094-23-6 6 FDA-DMF suppliersBiologic

Overview

Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in adults and children with diabetes mellitus. It is structurally similar to human insulin, with a rapid onset and short duration of action.

Therapeutic areas

Diabetes

Related APIs

Sitagliptin
50 suppliers
Semaglutide
48 suppliers
Empagliflozin
42 suppliers
Metformin
28 suppliers
Canagliflozin
23 suppliers
Dapagliflozin
22 suppliers
Glimepiride
19 suppliers
Repaglinide
18 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo